As President and CEO of the Massachusetts Biotechnology Council, Bob’s mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Over the last decade, Bob has truly become a champion for patients by ensuring innovative companies have the best environment possible to research, develop, and commercialize breakthrough therapies and cures for people around the world who need and deserve them. Bob has spent his career in both the public and private sectors. Before joining MassBio, he served as the Undersecretary of Economic Development within Governor Deval Patrick's administration, where he prioritized both healthcare and economic development issues and was a strong advocate for the life sciences industry in Massachusetts. Prior to that, he was elected as State Representative to the 11th Norfolk district for three terms. Bob has also held senior executive positions in the environmental services, capital management and venture capital industries. He brings passion and energy to all of his endeavors.

Lori is responsible for leading the Technical Sales Specialists that serve markets in Genotyping, Gene Expression, Clinical, Reproductive Health and Agrigenomics. The team of 50 employees spans across North America and is an integrated part of the Genetic Sciences Division commercial team. Lori has over 20 years of experience in the Life Science industry with various roles in marketing and sales. She joined Applied Biosystems in 1995 and throughout her career has focused bringing genomic solutions to market and leading sales teams to serve our customers’ needs.

Mark is President of Thermo Fisher Scientific’s Genetic Science Division. GSD is a $2B Global Business that serves the genetic analysis market with platforms and solutions in research, Human Identification, Clinical, Reproductive Health and Agribusiness market verticals. Mark previously held the position of Vice President, Europe, Middle East and Africa (EMEA), and was responsible for more than 3,300 employees and more than $1.4 billion of business across Europe, Middle East, Africa and CIS.